Long-term effects of giving nursing home residents bread fortified with 125 μg (5000 IU) vitamin D 3 per daily serving

American Journal of Clinical Nutrition

Volumn 89, Issue 4, 2009, Pages 1132-1137

  Mocanu, Veronica ^a   Stitt, Paul A ^b   Costan, Anca Roxana ^a   Voroniuc, Otilia ^a   Zbranca, Eusebie ^a   Luca, Veronica ^a   Vieth, Reinhold ^b,c  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; CREATININE; PARATHYROID HORMONE; 25-HYDROXYVITAMIN D; BONE DENSITY CONSERVATION AGENT; DRUG DERIVATIVE; VITAMIN D;

ADULT; AGED; ARTICLE; BONE DENSITY; BREAD; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HIP; HUMAN; HYPERCALCEMIA; LUMBAR SPINE; MALE; NURSING HOME PATIENT; NUTRIENT LOADING; PARATHYROID HORMONE BLOOD LEVEL; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; AGING; BLOOD; CALCIUM INTAKE; DIET SUPPLEMENTATION; DOSE RESPONSE; HOME FOR THE AGED; MIDDLE AGED; NURSING HOME; NUTRITIONAL ASSESSMENT; NUTRITIONAL REQUIREMENT; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; ROMANIA; URINE;

AGED; AGED, 80 AND OVER; AGING; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BREAD; CALCIUM; CALCIUM, DIETARY; CHOLECALCIFEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOOD, FORTIFIED; HOMES FOR THE AGED; HUMANS; MALE; MIDDLE AGED; NURSING HOMES; NUTRITION ASSESSMENT; NUTRITIONAL REQUIREMENTS; PARATHYROID HORMONE; ROMANIA; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 63649139745     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2008.26890     Document Type: Article

References (32)

1. Lips P, Wiersinga A, van Ginkel FC, et al. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab 1988;67:644-50.
2. Scharla SH. Prevalence of subclinical vitamin D deficiency in different European countries. Osteoporos Int 1998;8(suppl):S7-12.
3. van der Wielen RP, Lowik MR, van den Berg H, et al. Serum vitamin D concentrations among elderly people in Europe. Lancet 1995;346:207-10.
4. Larrosa M, Gratacos J, Vaqueiro M, Prat M, Campos F, Roque M. [Prevalence of hypovitaminosis D in elderly institutionalized residents: influence of a substitutive treatment.] Med Clin (Barc) 2001;117:611-4 (in Spanish).
5. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005;293:2257-64.
6. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 2005;16:713-6.
7. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84:18-28.
8. Grant AM, Avenell A, Campbell MK, et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 2005;365:1621-8.
9. Porthouse J, Cockayne S, King C, et al. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 2005;330:1003.
10. Tylavsky FA, Cheng S, Lyytikainen A, Viljakainen H, Lamberg-Allardt C. Strategies to improve vitamin d status in northern European children: exploring the merits of vitamin d fortification and supplementation. J Nutr 2006;136:1130-4.
11. Vieth R, Kimball S, Hu A, Walfish PG. Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutr J2004;3:8.
12. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003;77:204-10.
13. Aloia JF, Patel M, Dimaano R, et al. Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am J Clin Nutr 2008;87:1952-8.
14. 3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 2001;73:288-94.
15. Matsushita K, Tanikawa K. Significance of the calcium to creatinine concentration ratio of a single-voided urine specimen in patients with hypercalciuric urolithiasis. Tokai J Exp Clin Med 1987;12:167-71.
16. Lavocat MP, Freycon MT, Muchrif M. [Comparative study of 24-hour calciuria and urinary calcium/creatinine ratio in children over 4 years of age.] Pediatrie (Bucur) 1992;47:565-8 (in Romanian).
17. Gokce C, Gokce O, Baydinc C, et al. Use of random urine samples to estimate total urinary calcium and phosphate excretion. Arch Intern Med 1991;151:1587-8.
18. 18.Kimball S, Vieth R. Self-prescribed high-dose vitamin D3: effects on biochemical parameters in two men. Ann Clin Biochem 2008;45:106-10.
19. Bligh EG, Dyer WJ. A rapid metod of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-4.
20. Vieth R. The pharmacology of Vitamin D, including fortification strategies. In: Feldman D, Glorieux F, Pike JW, eds. Vitamin D. New York, NY: Elsevier, 2005:995-1015.
21. Heaney RP. The vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 2005;97:13-9.
22. Vieth R. Critique of the considerations for establishing the tolerable upper intake level for vitamin D: critical need for revision upwards. J Nutr 2006;136:1117-22.
23. Munro I. Derivation of tolerable upper intake levels of nutrients. Am J Clin Nutr 2001;74:865-7.
24. Yates AA, Schlicker SA, Suitor CW. Dietary Reference Intakes: the new basis for recommendations for calcium and related nutrients, B vitamins, and choline. J Am Diet Assoc 1998;98:699-706.
25. Johnson KR, Jobber J, Stonawski BJ. Prophylactic vitamin D in the elderly. Age Ageing 1980;9:121-7.
26. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999;69:842-56.
27. Geller JL, Hu B, Reed S, Mirocha J, Adams JS. Increase in bone mass after correction of vitamin D insufficiency in bisphosphonate-treated patients. Endocr Pract 2008;14:293-7.
28. Adami S, Giannini S, Bianchi G, et al. Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos Int 2008;20:239-44.
29. Al-Ali H, Fuleihan GE. Nutritional osteomalacia: substantial clinical improvement and gain in bone density posttherapy. J Clin Densitom 2000;3:97-101.
30. Barger-Lux MJ, Heaney RP. Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption. J Clin Endocrinol Metab 2002;87:4952-6.
31. 31.Vieth R. Vitamin D toxicity, policy, and science. J Bone Miner Res 2007;22(suppl 2):V64-8.
32. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007;85:1586-91.